Viking Therapeutics (VKTX) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Viking Therapeutics (VKTX) over the last 12 years, with Q4 2025 value amounting to 0.89.
- Viking Therapeutics' Equity Ratio fell 786.73% to 0.89 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.89, marking a year-over-year decrease of 786.73%. This contributed to the annual value of 0.89 for FY2025, which is 786.73% down from last year.
- Per Viking Therapeutics' latest filing, its Equity Ratio stood at 0.89 for Q4 2025, which was down 786.73% from 0.96 recorded in Q3 2025.
- In the past 5 years, Viking Therapeutics' Equity Ratio registered a high of 0.98 during Q1 2025, and its lowest value of 0.86 during Q4 2022.
- Its 5-year average for Equity Ratio is 0.94, with a median of 0.95 in 2021.
- In the last 5 years, Viking Therapeutics' Equity Ratio tumbled by 1002.1% in 2022 and then surged by 965.27% in 2023.
- Over the past 5 years, Viking Therapeutics' Equity Ratio (Quarter) stood at 0.96 in 2021, then decreased by 10.02% to 0.86 in 2022, then grew by 9.65% to 0.95 in 2023, then increased by 2.5% to 0.97 in 2024, then decreased by 7.87% to 0.89 in 2025.
- Its last three reported values are 0.89 in Q4 2025, 0.96 for Q3 2025, and 0.96 during Q2 2025.